A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy.

Clinicopathological Comparison Between nPD-L1 Positivity and Negativity In our study, the nPD-L1-positive group showed a trend toward an older median age (48 y vs 42 y, p=0.066) and higher PINK score (45.4% vs 37.8%, p=0.071) and a trend toward a lower CR rate after initial treatment (47.7% vs 67.6%, p=0.073) ( Table 2 ).

also in 53,322 other papers